Target intelligence / Profile preview

MicroRNA 29a-5p messenger RNA targets (miR-29a-5p targets)

Target
miR-29a-5p targets
Molecular classification
Messenger RNA, Nucleic acid
01

Overview

MicroRNA 29a-5p (miR-29a-5p) messenger RNA targets refer to the collective group of endogenous genes whose expression is post-transcriptionally regulated by the 5p strand of the miR-29a precursor. As a member of the miR-29 family, miR-29a-5p functions by binding to the 3' untranslated regions (UTRs) of specific mRNAs, facilitating their degradation or inhibiting their translation through the RNA-induced silencing complex (miRBase, 2023). Key validated targets of this microRNA family include DNA methyltransferases such as DNMT3A and DNMT3B, as well as anti-apoptotic factors like MCL1, which are critical in the progression of various cancers and epigenetic remodeling (PubMed: 17360452). Furthermore, miR-29a-5p is heavily involved in regulating extracellular matrix components and collagen production, making its target network a significant focus in the study of fibrotic and cardiovascular diseases (PubMed: 21103332). Therapeutic strategies often involve using miRNA mimics to suppress these targets or antagomirs to upregulate them; however, the broad regulatory reach of a single miRNA poses substantial challenges for drug specificity and safety. Consequently, monitoring the expression of these diverse mRNA targets is essential for evaluating the efficacy and potential off-target toxicity of miRNA-based therapeutics (PubMed: 24403312).

Other names
miR-29a-5p regulated geneshsa-miR-29a-5p targetsmiR-29a* targetsMicroRNA 29a-5p downstream targets
02

Mechanism of action

MicroRNA-29a-5p regulates gene expression by binding to complementary sequences in the 3' untranslated region (UTR) of target mRNAs, leading to translational repression or mRNA degradation via the RNA-induced silencing complex (RISC) (PubMed: 24403312).

03

Biological functions

Post-transcriptional gene regulationGene silencingRNA interferenceApoptosisCell differentiationExtracellular matrix organization
04

Disease associations

CancerFibrosisNeurodegenerative diseaseCardiovascular disease
05

Safety considerations

Off-target effects due to multi-gene regulationInnate immune activation (e.g., TLR7/8 stimulation)Saturation of the endogenous RNAi machinerySystemic delivery-related toxicity
06

Interacting drugs

MicroRNA-29a-5p mimics

3 more in the full profile.

07

Biomarkers

miR-29a-5p expression levelDNMT3A expression levelMCL1 expression levelCOL1A1 expression level

Beyond the preview

Go deeper on MicroRNA 29a-5p messenger RNA targets (miR-29a-5p targets).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 29a-5p messenger RNA targets (miR-29a-5p targets).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call